CELL INTELLIGENCE · 肿瘤细胞治疗研究

针对横纹肌肉瘤及其他 FGFR4 表达肿瘤的靶向抗体药物偶联物

Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.

揭示细胞系模型在顺势疗法研究中的潜力：综述

Unveiling the Potential of Cell Line Models in Homeopathic Research: A Review.

所综述的研究强调了顺势疗法在再生医学、癌症治疗和免疫调节方面的潜力。需要更多研究来评估其临床安全性和有效性。这些发现有助于推进靶向治疗，开辟新的医学研究和实践途径。

CAR-T 细胞治疗与外周实体瘤重建性肿瘤外科手术：叙述性综述

CAR-T cell therapy and reconstructive oncologic surgery in peripheral solid tumors-A narrative review.

进入场景：T(H)9 细胞向肺部优越的迁移能力解释了其卓越的抗癌疗效

Go to the scene: T(H)9 cells superior migration ability to the lungs explains their exceptional anticancer efficacy.

天然肺趋向性 T(H)9 细胞：对抗已形成的肺转移的利器

Natural lung-tropic T(H)9 cells: a sharp weapon for established lung metastases.

我们的发现强调了 T H 9 细胞由 TRAF6 激活驱动的固有肺趋向性，这支持了 T H 9 细胞作为已形成肺转移的有前景疗法的潜力。

肿瘤相关 NK 细胞通过 IL-6/STAT3 轴驱动 MDSC 介导的肿瘤免疫耐受

Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis.

骨肉瘤 HER2 靶向治疗的未来：德曲妥珠单抗阴性结果的启示

The Future of HER2-Targeted Treatment for Osteosarcoma: Lessons from the Negative Trastuzumab Deruxtecan Results.

靶向 4-1BB 的免疫治疗：机制、抗体与 CAR-T 细胞

4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T.

COPS6 通过抑制 IL-6 产生来促进肿瘤进展并减少 CD8(+) T 细胞浸润，从而促进乳腺癌的肿瘤免疫逃逸

COPS6 promotes tumor progression and reduces CD8(+) T cell infiltration by repressing IL-6 production to facilitate tumor immune evasion in breast can

胚胎型横纹肌肉瘤中 ERBB2（HER2）扩增：罕见病例中的潜在治疗靶点？

Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases?